-
Hyderabad: There are indications that the Omicron variant of SARS-CoV-2 has probably reached many Indian cities and is already there in the community. However, Indians have acquired strong seropositivity and the new virus will not find it easy to be transmissible, top genome expert and former Director of Hyderabad-based Center for Cellular and Molecular Biology […]
-
Amaravati: The health authorities in Andhra Pradesh are sending 15 per cent of Covid-19 positive samples for genome sequencing in view of the new variant Omicron, which has been reported in some countries. The health officials said the samples were being sent to the Centre for Cellular and Molecular Biology (CCMB) for genomic sequence to […]
-
Hyderabad: Hyderabad-based CSIR-Centre for Cellular and Molecular Biology (CCMB) celebrated its 34th Foundation Day here on Friday. Multiple activities were organised by the authorities for CCMB students, staff and public, which included research scholars presenting their work. The Foundation Day lecture was delivered by Dr Shekhar Mande, Director-General, Council of Scientific and Industrial Research (CSIR). […]
-
The ground-breaking study, which was published online recently in the journal Genes and Immunity, found that populations that carry similar long DNA segments (homozygous) in their genome are most likely to be more susceptible to Covid-19.
-
In their latest study, researchers have showed that the genes associated with smell (olfactory) and taste (gustation) were suppressed, causing Covid positive patients to lose their senses of smell and taste.
-
They have vital regulatory functions, reveals a study led by CCMB scientist
-
Recent studies by a team of geneticists from city-based Centre for Cellular and Molecular Biology (CCMB) has indicated ‘striking novel regulatory functions of Y chromosome DNA’.
-
Hyderabad: The Centre for Cellular and Molecular Biology (CCMB) is organising OMICS-2021, the 13th annual meeting of Proteomics Society of India (PSI) from October 20 to 23. The OMICS-2021 virtual conference, which is being organised by CCMB, PSI and CCMB Foundation with the theme ‘Omics in Redefining Biology’, will feature widespread discussions on cutting-edge developments […]
-
As part of the study, the researchers analysed DNA of 110 individuals from Roman Catholic community of Goa, Kumta and Mangalore.
-
No one group or individual can take credit for CSIR’s contributions in fighting Covid-19 and the entire credit goes to CSIR as an organisation, said Dr Shekhar C Mande, DG CSIR
-
Hyderabad: A latest study by researchers from Hyderabad-based Centre for Cellular and Molecular Biology (CCMB), published in peer-reviewed journal Science Advances, has thrown a new light on possible ways to develop better therapeutics related to cholesterol. In the study, CCMB researchers report a sensor region on human serotonin1A receptor that can detect cholesterol. They looked […]
-
Queen Ketevan is universally venerated by the Georgians for her courageous stand against the demand for forcible conversion.
-
Naidu also called for closer collaboration between zoos and research institutions that will help in studying diseases in wildlife and preserve genetic material of animals.
-
The special guidelines from LaCONES-CCMB have been released after Covid-19 was reported among zoo animals in the country
-
The consortium led by CCMB includes NCBS-TIFR, InStem-DBT and NIMHANS in Bengaluru, CSIR-IGIB in New Delhi, Pune Knowledge Cluster, IISER-Pune and CSIR-NCL in Pune
-
The multidisciplinary research unit at BHU collected about 130 samples for sequencing from Varanasi and areas around the city in April
-
Meril’s Extraction-free Dry Swab Kit can be used to isolate the viral RNA from dry swab samples and then can be directly used for RT-PCR
-
The CCMB’s technique eliminates need for expensive cold chain network
-
The drug can be added as a supplement or adjunct to the existing treatment protocols to treat moderate to severe Covid patients
-
The latest therapy with links to the city is the glucose molecule 2-DG and its anti-Covid-19 therapeutic application that was given a green signal by Indian drug regulatory authorities
